Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,017 Cr₹853 Cr₹713 Cr₹617 Cr₹512 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,017 Cr
Mar2023₹853 Cr
Mar2022₹713 Cr
Mar2021₹617 Cr
Mar2020₹512 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2024 ₹1,017 Cr
19.20
Mar2023 ₹853 Cr
19.67
Mar2022 ₹713 Cr
15.56
Mar2021 ₹617 Cr
20.42
Mar2020 ₹512 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹18,901.2 Cr 2.6% -12.3% 6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

2.6%

-12.3%

6.6%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses